BSH 2019 | MRD in pediatric ALL: clinical evidence, treatment decisions & outcomes

Vaskar Saha

Vaskar Saha, MBBS, DCH, MD, FRCP, FRCPath, PhD, University of Manchester, Manchester, UK, speaks at the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK. He discusses the emerging clinical evidence for measurable residual disease (MRD) in pediatric acute lymphoblastic leukemia (ALL) and how is this impacting treatment decisions.

Share this video